Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 5 points (0.0%) at 16,485 as of Friday, Dec. 27, 2013, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,370 issues advancing vs. 1,569 declining with 149 unchanged. The Health Services industry currently sits down 0.2% versus the S&P 500, which is unchanged. Top gainers within the industry include Intuitive Surgical ( ISRG), up 2.0%, and Express Scripts ( ESRX), up 0.5%. A company within the industry that fell today was Opko Health ( OPK), up 2.4%. TheStreet would like to highlight 4 stocks pushing the industry higher today: 4. Fresenius Medical Care AG & Co. KGaA ( FMS) is one of the companies pushing the Health Services industry higher today. As of noon trading, Fresenius Medical Care AG & Co. KGaA is up $0.18 (0.5%) to $35.40 on light volume. Thus far, 25,533 shares of Fresenius Medical Care AG & Co. KGaA exchanged hands as compared to its average daily volume of 137,500 shares. The stock has ranged in price between $35.40-$35.63 after having opened the day at $35.62 as compared to the previous trading day's close of $35.22. Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, operates in the field of dialysis care and dialysis products for the treatment of end-stage renal disease. Fresenius Medical Care AG & Co. KGaA has a market cap of $21.1 billion and is part of the health care sector. Shares are up 2.7% year to date as of the close of trading on Thursday. Currently there are 2 analysts that rate Fresenius Medical Care AG & Co. KGaA a buy, no analysts rate it a sell, and 8 rate it a hold. TheStreet Ratings rates Fresenius Medical Care AG & Co. KGaA as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Fresenius Medical Care AG & Co. KGaA Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.